68 related articles for article (PubMed ID: 1642027)
1. [How painful is intensive insulin therapy?].
Lee DM
Z Gesamte Inn Med; 1992 Jun; 47(6):266-9. PubMed ID: 1642027
[TBL] [Abstract][Full Text] [Related]
2. Low discomfort and pain associated with intensified insulin therapy in children and adolescents.
Karges B; Muche R; Moritz M; Riegger I; Debatin KM; Heinze E; Wabitsch M; Karges W
Diabetes Res Clin Pract; 2008 Apr; 80(1):96-101. PubMed ID: 18160119
[TBL] [Abstract][Full Text] [Related]
3. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
4. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
[TBL] [Abstract][Full Text] [Related]
5. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
6. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
7. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
de Meijer PH; Lutterman JA
Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
[TBL] [Abstract][Full Text] [Related]
9. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
Navascués I; Kerner W; Pfeiffer EF
Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
[TBL] [Abstract][Full Text] [Related]
10. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
[TBL] [Abstract][Full Text] [Related]
11. Reliability of the Diabetes Fear of Injecting and Self-Testing Questionnaire in pediatric patients with type 1 diabetes.
Simmons JH; McFann KK; Brown AC; Rewers A; Follansbee D; Temple-Trujillo RE; Klingensmith GJ
Diabetes Care; 2007 Apr; 30(4):987-8. PubMed ID: 17392558
[No Abstract] [Full Text] [Related]
12. [Injection site for quick-acting insulin. Significance for glycemic control in basal bolus insulin regimen].
Henriksen JE; Djurhuus MS; Vaag AA; Thye-Rønn P; Knudsen DU; Nielsen OH; Beck-Nielsen H
Ugeskr Laeger; 1994 Aug; 156(35):4976-9. PubMed ID: 7992431
[TBL] [Abstract][Full Text] [Related]
13. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.
Rave K; Klein O; Frick AD; Becker RH
Diabetes Care; 2006 Aug; 29(8):1812-7. PubMed ID: 16873785
[TBL] [Abstract][Full Text] [Related]
14. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
Roos AN; Meinders AE
Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
[TBL] [Abstract][Full Text] [Related]
15. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
16. [Fear of long-term injections. Insulin therapy--soon treatment also without injection].
MMW Fortschr Med; 2002 Jun; 144(23):8. PubMed ID: 12119913
[No Abstract] [Full Text] [Related]
17. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
[TBL] [Abstract][Full Text] [Related]
18. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences.
Fisken RA; Goulbourn J
Diabetes Res; 1989 Aug; 11(4):195-7. PubMed ID: 2696619
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous tissue thickness in children with type 1 diabetes.
Shin H; Kim MJ
J Adv Nurs; 2006 Apr; 54(1):29-34. PubMed ID: 16553688
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
